https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
Alphabet’s secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, Isomorphic Labs president and Google DeepMind’s chief business officer, told Fortune. “There are people sitting in our office in King’s Cross, London, working, and collaborating with AI to design drugs for cancer,” Murdoch said during … Read more
Demis Hassabis, Co-Founder and CEO of Google DeepMind and Nobel Prize Laureate in Chemistry 2024, attends the Artificial Intelligence (AI) Action Summit at the Grand Palais in Paris, France, February 10, 2025. Benoit Tessier | Reuters On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from … Read more
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV and existing investor Alphabet, Google’s parent, it said. The funding will accelerate further development of Isomorphic’s AI drug … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4